Dominic Marasco - 23 Jun 2025 Form 4 Insider Report for MANNKIND CORP (MNKD)

Reporting relationship: Pres, Endocrine Business Unit
Issuer ticker: MNKD
Reported as of: 23 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2025, 21:00:08 UTC
Prior SEC filing: 16 May 2025
Next SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dominic Marasco

Key filing fact

Dominic Marasco filed Form 4 for MANNKIND CORP (MNKD) on 25 Jun 2025.

Key facts

This page summarizes Dominic Marasco's Form 4 filing for MANNKIND CORP (MNKD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2025, 21:00.

Change

Previous filing in this sequence was filed on 16 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002053897 Primary reporting owner

Marasco Dominic

Relationship: Pres, Endocrine Business Unit
Address: 1 CASPER STREET, DANBURY
Signature: /s/ Dominic Marasco
Signature date: 25 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNKD transaction Derivative

Performance Restricted Stock Unit

Award

Transaction value: $0
Shares: +1,000,000
Change %
Price: $0.000000
Shares after: 1,000,000
Date: 23 Jun 2025
Ownership: Direct
Underlying class: Common Stock, $0.01 Par Value
Underlying amount: 1,000,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.

Footnote F2

The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%.